Tin tức & Cập nhật

Oral lasofoxifene helps improve genitourinary syndrome of menopause

Oral lasofoxifene at either 0.25 or 0.5 mg daily confers benefits on genitourinary syndrome of menopause, with pooled data from two phase III trials showing significant improvements in vaginal signs or symptoms while having a favourable safety profile.

Antenatal corticosteroid exposure poses no major threat to infant neurodevelopment

Children who were exposed antenatally to betamethasone as opposed to placebo are not necessarily at a disadvantage in terms of neurodevelopment outcomes, as shown in a follow-up to the Antenatal Late Preterm Steroids (ALPS) trial.

Maternal fish oil supplementation tied to overweight in children

Children of mothers who took n‒3 long-chain polyunsaturated fatty acid (LCPUFA) supplements during pregnancy tend to have an increased body mass index (BMI) at age 10 years, a higher risk of being overweight, and greater fat percentage and metabolic syndrome score, a study has shown.

Intranasal zavegepant offers freedom from pain in women with acute migraine

The use of nasal spray zavegepant 10 mg provides freedom from pain and the most bothersome migraine symptom (MBS*) at 2 hours after treatment in women with acute migraine, according to the pooled analysis of the two trials presented at AAN 2024.

[MIMS Education] Điều trị đau bụng kinh với nhóm kháng viêm không steroid (NSAID) - P2

Bài viết trích từ nội dung khóa học trên MIMS Education

Sau khi đã nắm được tổng quan về mức độ phổ biến, phân loại và các nguyên nhân thường gặp của tình trạng đau bụng kinh ở phần 1, ở phần tiếp theo chúng ta hãy cùng tìm hiểu về phương pháp giảm đau với nhóm thuốc NSAID với những lưu ý về thời gian và liều dùng nhé!